The abstract is read at the publisher; the summary is JClub's.
Combining glaucoma diagnosis with treatment evidence in UK Biobank participants yields stronger associations with severity biomarkers than diagnosis-only definitions, e.g., IOPcc OR 23.6 vs 11.4.
- Why it matters: Diagnostic-only case definitions may dilute links between established risk factors, severity biomarkers, and glaucoma status in population biobanks.
- What they did: In an observational cohort of 503,325 UK Biobank participants, odds ratios were compared for risk factors (IOPcc, PRS) and severity biomarkers (mRNFL, mGCL) across diagnosis-only (n=16,154) versus diagnosis-and-treatment (n=7,012) glaucoma groups.
- The result: For the highest 5% IOPcc, ORs were 23.6 (95% CI, 21.3–26.2) in diagnosis-and-treatment versus 11.4 (95% CI, 10.6–12.3) in diagnosis-only, with similar stronger patterns for thinnest 5% mRNFL, mGCL, and highest 5% PRS.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.